Skip to main content

Psoriasis

ALN
A patient with psoriasis tells you he is interested in getting a tattoo. Would you have any clinical concerns about your patient getting the tattoo? Let us know by taking our poll.
The Dermatologist
Results from a recent study suggested a possible increased risk of serious cardiovascular events among patients with high cardiovascular risk before initiating ustekinumab.
ALN
Findings from a recent analysis of phase 3 AMAGINE-2 and AMAGINE-3 trials showed greater benefit with brodalumab compared with ustekinumab for patients with psoriasis.
The Dermatologist
A recent study demonstrated the safety and long-term effectiveness of bimekizumab, with participants maintaining high PASI scores through 60 weeks of treatment.
The Dermatologist
Psoriasis is associated with many comorbid conditions. In an interview with The Dermatologist, Ronald Prussick, MD, discusses the latest research on these comorbidities, evidence on lifestyle and treatment options that could potentially prevent or manage both psoriasis and comorbid conditions, and the importance of screening and aggressively treating psoriatic arthritis.
Back to Top